» Articles » PMID: 30501624

Clinical and Other Specialty Services Offered by Pharmacists in the Community: the International Arena and Israel

Overview
Publisher Biomed Central
Date 2018 Dec 4
PMID 30501624
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The community pharmacy setting is a venue that is readily accessible to the public. In addition, it is staffed by a pharmacist, who is a healthcare provider, trained and capable of delivering comprehensive pharmaceutical care. As such, community pharmacists have a colossal opportunity to serve as key contributors to patients' health by ensuring appropriate use of medications, preventing medication misadventures, identifying drug-therapy needs, as well as by being involved in disease management, screening, and prevention programs. This unique position gives the pharmacist the privilege and duty to serve patients in roles other than solely that of the stereotypical drug dispenser.Worldwide, as well as in Israel, pharmacists already offer a variety of pharmaceutical services and tend to patients' and the healthcare system's needs. This article provides examples of professional, clinical or other specialty services offered by community pharmacists around the world and in Israel and describes these interventions as well as the evidence for their efficacy. Examples of such activities which were recently introduced to the Israeli pharmacy landscape due to legislative changes which expanded the pharmacist's scope of practice include emergency supply of medications, pharmacists prescribing, and influenza vaccination. Despite the progress already made, further expansion of these opportunities is warranted but challenging. Independent prescribing, as practiced in the United Kingdom or collaborative drug therapy management programs, as practiced in the United States, expansion of vaccination programs, or wide-spread recognition and reimbursement for medication therapy management (MTM) programs are unrealized opportunities. Obstacles such as time constraints, lack of financial incentives, inadequate facilities and technology, and lack of professional buy-in, and suggested means for overcoming these challenges are also discussed.

Citing Articles

Community pharmacist's perspective regarding patient-centred communication in conjunction with pharmaceutical practice: A cross-sectional survey.

Rusu A, Chereches M, Popa C, Botezatu R, Lungu I, Moldovan O Saudi Pharm J. 2022; 30(9):1327-1344.

PMID: 36249938 PMC: 9561180. DOI: 10.1016/j.jsps.2022.06.014.


The Influence of the Pharmacists' Training on the Quality and Comprehensiveness of Professional Advice Given in the Field of Inhalation Techniques in Community Pharmacies in Poland.

Waszyk-Nowaczyk M, Guzenda W, Targosz P, Byliniak M, Plewka B, Dabrowiecki P Int J Environ Res Public Health. 2022; 19(4).

PMID: 35206255 PMC: 8872325. DOI: 10.3390/ijerph19042071.


Seven key parameters that facilitate clinical pharmacy practice: a comparison between Israel and the United States.

Rose A, Witt D, Azran C, Nissan R Isr J Health Policy Res. 2021; 10(1):37.

PMID: 34193277 PMC: 8246679. DOI: 10.1186/s13584-021-00476-8.


The Excellence of Pharmacy Practice.

Mohiuddin A Innov Pharm. 2021; 11(1).

PMID: 34017646 PMC: 8132542. DOI: 10.24926/iip.v11i1.1662.


Enhancing primary care and preventive services through Interprofessional practice and education.

Fowler T, Garr D, Mager N, Stanley J Isr J Health Policy Res. 2020; 9(1):12.

PMID: 32204734 PMC: 7092466. DOI: 10.1186/s13584-020-00371-8.

References
1.
Gallagher P, OMahony D . STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing. 2008; 37(6):673-9. DOI: 10.1093/ageing/afn197. View

2.
Shord S, Schwinghammer T, Badowski M, Banderas J, Burton M, Chapleau C . Desired professional development pathways for clinical pharmacists. Pharmacotherapy. 2013; 33(4):e34-42. DOI: 10.1002/phar.1251. View

3.
Garcia-Cardenas V, Sabater-Hernandez D, Kenny P, Martinez-Martinez F, Faus M, Benrimoj S . Effect of a pharmacist intervention on asthma control. A cluster randomised trial. Respir Med. 2013; 107(9):1346-55. DOI: 10.1016/j.rmed.2013.05.014. View

4.
Twigg G, Motsko J, Thomas J, David T . Pharmacist-Managed Diabetes Center Interventions Ensure Quality and Safety in Elderly Patients. Consult Pharm. 2017; 32(5):299-310. DOI: 10.4140/TCP.n.2017.299. View

5.
Garfinkel D, Mangin D . Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010; 170(18):1648-54. DOI: 10.1001/archinternmed.2010.355. View